# Morishita Jintan Co., Ltd. – FDA Inspection, May 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/morishita-jintan-co-ltd/fa7dae60-b969-43b4-8532-43cb76a8deb0
Source feed: FDA_Inspections

> FDA inspection 1207312 of Morishita Jintan Co., Ltd., May 19, 2023. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1207312
- Company Name: Morishita Jintan Co., Ltd.
- Inspection Date: 2023-05-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- FDA Inspection 1088942 - 2018-11-30
- FDA Inspection 808340 - 2012-11-07
- FDA Inspection 785570 - 2012-02-03

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/saundrea-a-munroe/129a869f-e1f2-4d59-b3ed-9613a9190f8a)

Company: https://www.keypedia.com/companies/morishita-jintan-co-ltd/60905237-f2c7-470f-b321-b46547c1f7df

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c